BioGX RT-PCR assays protect your healthcare environment with rapid detection of Candida auris, compatible on BD MAX, Bio-Rad CFX and QuantStudio
The sudden emergence of Candida auris has gained global interest due to the high rate of invasive infection in hospitals and long-term care facilities. The risk of misidentifying Candida auris is severe and can lead to incorrect treatment, rapid transmission amongst patients and potential death of up to 30-60%. Molecular diagnostic testing methods are essential for effective detection of Candida auris, as set by the CDC.
Early detection is paramount. The BioGX Candida auris RT-PCR assay is a complete assay in a single vial, lyophilized in the trusted BioGX Sample-Ready™ format, fine-tuned to ensure high performance for the accurate identification of Candida auris.